Update in pulmonary hypertension 2005

被引：32

作者：

Hoeper, MM ^{[1
]}

Rubin, LJ

机构：

[1] Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany

[2] Univ Calif San Diego, Pulm Vasc Program, La Jolla, CA 92093 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2006年 / 173卷 / 05期

关键词：

D O I：

10.1164/rccm.2512003

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：499 / 505

页数：7

共 92 条

[61] Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells [J].

Nishimura, T ;

Vaszar, LT ;

Faul, JL ;

Zhao, GH ;

Berry, GJ ;

Shi, LF ;

Qiu, DM ;

Benson, G ;

Pearl, RG ;

Kao, PN .

CIRCULATION, 2003, 108 (13) :1640-1645

[62]

NUNES H, 2005, THORAX

[63] Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension [J].

Opitz, CF ;

Wensel, R ;

Winkler, J ;

Halank, M ;

Bruch, L ;

Kleber, FX ;

Höffken, G ;

Anker, SD ;

Negassa, A ;

Felix, SB ;

Hetzer, R ;

Ewert, R .

EUROPEAN HEART JOURNAL, 2005, 26 (18) :1895-1902

[64] Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension [J].

Paul, GA ;

Gibbs, JSR ;

Boobis, AR ;

Abbas, A ;

Wilkins, MR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (01) :107-112

[65] cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling [J].

Phillips, PG ;

Long, L ;

Wilkins, MR ;

Morrell, NW .

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 288 (01) :L103-L115

[66] Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension [J].

Pullamsetti, S ;

Kiss, L ;

Ghofrani, HA ;

Voswinckel, R ;

Haredza, P ;

Klepetko, W ;

Aigner, C ;

Fink, L ;

Muyal, JP ;

Weissmann, N ;

Grimminger, F ;

Seeger, W ;

Schermuly, RT .

FASEB JOURNAL, 2005, 19 (06) :1175-+

[67] Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension [J].

Richalet, JP ;

Gratadour, P ;

Robach, P ;

Pham, I ;

Déchaux, M ;

Joncquiert-Latarjet, A ;

Mollard, P ;

Brugniaux, J ;

Cornolo, J .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (03) :275-281

[68] Impaired transforming growth factor-β signaling in idiopathic pulmonary arterial hypertension [J].

Richter, A ;

Yeager, ME ;

Zaiman, A ;

Cool, CD ;

Voelkel, NF ;

Tuder, RM .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (12) :1340-1348

[69] Bosentan therapy for pulmonary arterial hypertension [J].

Rubin, LJ ;

Badesch, DB ;

Barst, RJ ;

Galiè, N ;

Black, CM ;

Keogh, A ;

Pulido, T ;

Frost, A ;

Roux, S ;

Leconte, I ;

Landzberg, M ;

Simonneau, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :896-903

[70] Lack of circulating autoantibodies to bone morphogenetic protein receptor-II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension [J].

Satoh, T ;

Kimura, K ;

Okano, Y ;

Hirakata, M ;

Kawakami, Y ;

Kuwana, M .

RHEUMATOLOGY, 2005, 44 (02) :192-196

← 1 2 3 4 5 6 7 8 9 10 →